Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up

AIDS Research and Human Retroviruses

Volumn 15, Issue 15, 1999, Pages 1325-1332

  Janssens, Wouter ^a   Nkengasong, John ^a   Heyndrickx, Leo ^a   Van Der Auwera, Gert ^a   Vereecken, Katleen ^a   Coppens, Sandra ^a   Willems, Betty ^a   Beirnaert, Els ^a   Fransen, Katrien ^a   Peeters, Martine ^b   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; DISEASE COURSE; ENVELOPE GENE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS ISOLATION;

EID: 0033544018     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310025     Document Type: Article

References (34)

1. Charneau P, Borman AM, Quillant C, Guétard D, Chamaret S, Cohen J, Rémy G, Montagnier L, and Clavel F: Isolation and envelope sequence of a highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 1994;205:247-253.
2. Simon F, Mauclère P, Roques P, Loussert-Ajaka I, Müller-Trutwin MC, Saragosti S, Georges-Courbot MC, Barré-Sinoussi F, and Brun-Vézinet F: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nature Med 1998;4:1032-1037.
3. Vanden Haesevelde M, Decourt J-L, De Leys RJ, Vanderborght B, van der Groen G, Van Heuverswyn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994;68: 1586-1596.
4. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knap S, Zekeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-1585.
5. Temin HM: Retrovirus variation and reverse transcription: Abnormal strand transfer results in retrovirus genetic variation. Proc Natl Acad Sci USA 1993;90:6900-6903.
6. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
7. Nkengasong JN, Fransen K, Willems B, Karita E, Vingerhoets J, Kestens L, Colebunders R, Piot P, and van der Groen G: Virologic, immunologic, and clinical follow up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol 1997;51:202-209.
8. De Leys R, Vanderborght B, Vanden Haesevelde M, Heyndrickx L, van Geel A, Wauters A, Bernaerts R, Saman E, Nys P, Willems B, Taelman H, van der Groen G, Piot P, Tersmette T, Huisman JG, and Van Heuverswyn H: Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-1216.
9. Beirnaert E, Willems B, Peeters M, Bouckaert A, Heyndrickx L, Zhong P, Vereecken K, Coppens S, Davis D, Ndumbe P, Janssens W, and van der Groen G: Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capturing assay. J Virol Methods 1998;73:65-70.
10. Cecilia D, Kewalramani VN, O'Leary J, Volsky B, Nyambi P, Burda S, Xu S, Littman DR, and Zolla-Pazner S: Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998;72:6988-6996.
11. Van Kerckhoven I, Fransen K, Peeters M, De Beenhouwer H, Piot P, and van der Groen G: Quantification of human immunodeficiency virus in plasma by RNA-PCR: Viral culture and p24 antigen detection. J Clin Microbiol 1994;7:1669-1673.
12. Loussert-Ajaka I, Chaix M-L, Korber B, Letourneur F, Gomas E, Allen E, Ly T-D, Brun-Vézinet F, Simon F, and Saragosti S: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-5649.
13. Myers G, Korber B, Foley B, Jeang K-T, Mellors JW, and Wain-Hobson S: Human Retroviruses and AIDS 1996. Los Alamos National Laboratory, Los Alamos, New Mexico, 1996.
14. Hunt JC, Golden AM, Lund JK, Gürtler LG, Zekeng L, Obiang J, Kaptué L, Hampl H, Vallari A, and Devare SG: Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from Equatorial Guinea. AIDS Res Hum Retroviruses 1997;13:995-1005.
15. Janssens W, Heyndrickx L, Van der Auwera G, Nkengasong J, Beirnaert E, Vereecken K, Coppens S, Willems B, Fransen K, Peelers M, Ndumbe P, Delaporte E, and van der Groen G: Interpatient genetic variability of HIV-1 group O. AIDS 1998;13:41-48.
16. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
17. De Rijk P and De Wachter R: DCSE, an interactive tool for sequence alignment and secondary structure research. Comput Appl Biosci 1993;9:735-740.
18. Van de Peer Y and De Wachter R: TREECON for Windows: A software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci 1994;10:569-570.
19. Kumar S, Tamura K, and Nei M: MEGA: Molecular Evolutionary Genetics Analysis, version 1.01. The Pennsylvania State University, University Park, Pennsylvania, 1993.
20. De Jong J, Simon F, van der Groen G, Baan E, Saragosti S, Brun-Vézinet F, and Goudsmit J: V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT2 cells. AIDS Res Hum Retroviruses 1996;12: 1503-1507.
21. Tsang ML, Evana LA, McQueen I, Hurren L, Byrne C, Penny R, Tindall B, and Copper DA: Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion. J Infect Dis 1994;170:1141-1147.
22. Delwart EL, Pan H, Sheppard HW, Wolpert D, Neumann AU, Korber B, and Mullins JI: Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol 1997;71:7498-7508.
23. Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, and Chen ISY: Rapid generation of sequence variation during primary HIV-1 infection. AIDS 1992;6:453-460.
24. Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kuntsman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT, and Koup RA: Adaptive evolution of HIV-1 during the natural course of infection. Science 1996;272:537-542.
25. McNearny T, Hornickova Z, Markham R, Birdwell A, and Arens M: Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci USA 1992;89:10247-10251.
26. Shankarappa R, Gupta P, Learn Jr GH, Rodrigo AG, Rinaldo CR Jr, Gorry MC, Mullins JI, Nara PL, and Ehrlich GD: Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology 1998;241:251-259.
27. Gürtler L, Zekeng L, Eberte J, von Brunn A, and Kaptue L: Quasispecies heterogeneity in two HIV-1 subtype O infected patients in consecutive bleedings. In: XIth International Conference on AIDS, Vancouver, July 7-12, 1996, Vol. 1: Abstracts. Tu.A.2062, p. 276.
28. Korber B, Loussert-Ajaka I, Blouin J, and Saragosti S: A comparison of HIV-1 group M and group O functional and immunogenic domains in the gag p24 protein and the C2V3 region of the envelope protein. In: Human Retroviruses and AIDS 1996. (Myers G, Korber B, Foley B, Jeang K-T, Mellors JW, and Wain-Hobson S, eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1996, pp. III-41-55.
29. Nielsen R and Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998;148:929-936.
30. Bonhoeffer S, Holmes EC, and Nowak MA: Causes of HIV diversity. Nature (London) 1995;376:125.
31. Mindell DP: Positive selection and rates of evolution in immunodeficiency viruses from humans and chimpanzees. Proc Natl Acad Sci USA 1996;93:3284-3288.
32. Yamaguchi Y and Gojobori T: Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc Natl Acad Sci USA 1997;94:1264-1269.
33. Nyambi P, Nkengasong J, Peeters M, Simon F, Eberle J, Janssens W, Fransen K, Willems B, Vereecken K, Heyndrickx L, Piot P, and van der Groen G: Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HTV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis 1995;172:1228-1237.
34. Nyambi P, Nkengasong J, Lewi P, Andries K, Janssens W, Fransen K, Heyndrickx L, Piot P, and van der Groen G: Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol 1996;70:6235-6243.